Tarsus Pharmaceuticals Stock Price Prediction
| TARS Stock | USD 51.74 1.33 2.51% |
Oversold Vs Overbought
36
Oversold | Overbought |
EPS Estimate Next Quarter (0.95) | EPS Estimate Current Year (3.27) | EPS Estimate Next Year (1.91) | Wall Street Target Price 67.1111 | EPS Estimate Current Quarter (0.94) |
Using Tarsus Pharmaceuticals hype-based prediction, you can estimate the value of Tarsus Pharmaceuticals from the perspective of Tarsus Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Tarsus Pharmaceuticals using Tarsus Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Tarsus using crowd psychology based on the activity and movement of Tarsus Pharmaceuticals' stock price.
Tarsus Pharmaceuticals Implied Volatility | 0.79 |
Tarsus Pharmaceuticals' implied volatility exposes the market's sentiment of Tarsus Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Tarsus Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Tarsus Pharmaceuticals stock will not fluctuate a lot when Tarsus Pharmaceuticals' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Tarsus Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Tarsus because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Tarsus Pharmaceuticals after-hype prediction price | USD 51.9 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Tarsus contract
Based on the Rule 16, the options market is currently suggesting that Tarsus Pharmaceuticals will have an average daily up or down price movement of about 0.0494% per day over the life of the 2025-04-17 option contract. With Tarsus Pharmaceuticals trading at USD 51.74, that is roughly USD 0.0255 . If you think that the market is fully incorporating Tarsus Pharmaceuticals' daily price movement you should consider acquiring Tarsus Pharmaceuticals options at the current volatility level of 0.79%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Tarsus |
Tarsus Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Tarsus Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Tarsus Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Tarsus Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Tarsus Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Tarsus Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Tarsus Pharmaceuticals' historical news coverage. Tarsus Pharmaceuticals' after-hype downside and upside margins for the prediction period are 49.00 and 54.80, respectively. We have considered Tarsus Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Tarsus Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of Tarsus Pharmaceuticals is based on 3 months time horizon.
Tarsus Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Tarsus Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Tarsus Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Tarsus Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.23 | 2.91 | 0.21 | 0.07 | 10 Events / Month | 15 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
51.74 | 51.90 | 0.33 |
|
Tarsus Pharmaceuticals Hype Timeline
Tarsus Pharmaceuticals is at this time traded for 51.74. The entity has historical hype elasticity of -0.21, and average elasticity to hype of competition of -0.07. Tarsus is projected to increase in value after the next headline, with the price projected to jump to 51.9 or above. The average volatility of media hype impact on the company the price is over 100%. The price appreciation on the next news is projected to be 0.33%, whereas the daily expected return is at this time at 0.23%. The volatility of related hype on Tarsus Pharmaceuticals is about 972.95%, with the expected price after the next announcement by competition of 51.67. The company reported the previous year's revenue of 17.45 M. Net Loss for the year was (135.89 M) with profit before overhead, payroll, taxes, and interest of 107.2 M. Given the investment horizon of 90 days the next projected press release will be in about 10 days. Check out Tarsus Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Tarsus Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Tarsus Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Tarsus Pharmaceuticals' future price movements. Getting to know how Tarsus Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Tarsus Pharmaceuticals may potentially react to the hype associated with one of its peers.
Tarsus Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Tarsus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Tarsus using various technical indicators. When you analyze Tarsus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Tarsus Pharmaceuticals Predictive Indicators
The successful prediction of Tarsus Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Tarsus Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Tarsus Pharmaceuticals based on analysis of Tarsus Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Tarsus Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Tarsus Pharmaceuticals's related companies. | 2023 | 2024 | 2025 (projected) | Payables Turnover | 0.0878 | 0.079 | 0.075 | Days Of Inventory On Hand | 711.9 | 640.71 | 701.51 |
Story Coverage note for Tarsus Pharmaceuticals
The number of cover stories for Tarsus Pharmaceuticals depends on current market conditions and Tarsus Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Tarsus Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Tarsus Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Tarsus Pharmaceuticals Short Properties
Tarsus Pharmaceuticals' future price predictability will typically decrease when Tarsus Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Tarsus Pharmaceuticals often depends not only on the future outlook of the potential Tarsus Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Tarsus Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 29.4 M | |
| Cash And Short Term Investments | 227.4 M |
Additional Tools for Tarsus Stock Analysis
When running Tarsus Pharmaceuticals' price analysis, check to measure Tarsus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tarsus Pharmaceuticals is operating at the current time. Most of Tarsus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tarsus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tarsus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tarsus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.